mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |